Intratumoral Immunotherapy: Is It Ready for Prime Time?
Ghosn M, Tselikas L, Champiat S, Deschamps F, Bonnet B, Carre É, Testan M, Danlos FX, Farhane S, Susini S, Suzzoni S, Ammari S, Marabelle A, De Baere T.
Ghosn M, et al. Among authors: bonnet b.
Curr Oncol Rep. 2023 Aug;25(8):857-867. doi: 10.1007/s11912-023-01422-4. Epub 2023 May 2.
Curr Oncol Rep. 2023.
PMID: 37129706
Review.